Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes ; volume:15 ; number:1 ; day:10 ; month:7 ; year:2015 ; pages:1-13 ; date:12.2015
BMC cancer ; 15, Heft 1 (10.7.2015), 1-13, 12.2015
- Creator
-
Khan, Faizan H.
- Contributor
-
Pandian, Vijayabaskar
Ramraj, Satishkumar
Natarajan, Mohan
Aravindan, Sheeja
Herman, Terence S.
Aravindan, Natarajan
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1463-y
- URN
-
urn:nbn:de:1111-2016110616529
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khan, Faizan H.
- Pandian, Vijayabaskar
- Ramraj, Satishkumar
- Natarajan, Mohan
- Aravindan, Sheeja
- Herman, Terence S.
- Aravindan, Natarajan
- SpringerLink (Online service)
Other Objects (12)
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Dictate vom Kreistag
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Dictate von den Ulmer Kreistagen
Dictate über Ideal- und Naturphilosophie
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Dictate vom Kreistag
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Dictate von den Ulmer Kreistagen
Dictate über Ideal- und Naturphilosophie
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Dictate vom Kreistag
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Dictate von den Ulmer Kreistagen